The Vaccination against Human Papillomavirus Infection and New Alternatives in Laboratory Diagnosis
Keywords:
Human papillomavirus, HPV infection diagnosis, HPV vaccine, Cervical cancerAbstract
The Human papillomavirus (HPV) is an infection transmitted through sexual contact. HPV infection can occur in both men and women. HPV infection leads to the development of genital warts, anal cancer, and cervical cancer. This article discusses the HPV infection that leads to the development of cervical cancer in women. This is a significant public health issue in Thailand.
There are various strains of HPV, with high-risk strains playing a crucial role in the cellular changes that lead to cervical cancer. HPV infection prevalence across regions in Thailand between 1989-2020, found that the total HPV infection rate was 40.47%. Vaccination against HPV is considered an effective method to reduce cervical cancer rates because condom use during sexual intercourse does not completely prevent HPV transmission. This article reviews the current knowledge on the prevalence of HPV infection and new alternatives to laboratory diagnostic methods and prevention strategies. A comprehensive understanding of HPV may contribute to reducing infection rates and lowering the incidence of cervical cancer in women.
References
Institute NC. Hospital-based cancer registry 2022 [internet]. 2023 [cite 2024 Nov 25] Available from: https://www.nci.go.th/th/cancer_record/download/Hosbased-2022-1.pdf.
ประเสริฐชัย อ, เหล่ารุจิสวัสดิ์ ม. แนวโน้มอัตราการตายด้วยโรคมะเร็งปากมดลูกในประเทศไทยระหว่างปี พ.ศ.2554-2564.วารสารความปลอดภัยและสุขภาพ. 2566; 16(1):203-17.
Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020; 40(5):602-8.
Mariani L, Preti M, Cristoforoni P, Stigliano CM, Perino A. Overview of the benefits and potential issues of the nonavalent HPV vaccine. Int J Gynaecol Obstet. 2017; 136(3):258-65.
Mir BA, Ahmad A, Farooq N, et al. Increased expression of HPV-E7 oncoprotein correlates with a reduced level of pRb proteins via high viral load in cervical cancer. Sci Rep. 2023; 13:15075.
Yu L, Majerciak V, Zheng ZM. HPV 16 and HPV18 Genome Structure, Expression, and Post- Transcriptional Regulation. Int J Mol Sci. 2022; 23(9):494-3.
Nelson CW, Mirabello L. Human papillomavirus genomics: Understanding carcinogenicity. Tumour Virus Res. 2023; 15:200258.
Cubie HA. Diseases associated with human papillomavirus infection. Virology. 2013; 445(1-2):21-34.
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6):518-27.
เทียนเเสง พันธ์ศรี, กฤติกา บุญมาก, จรัญญา งามขำ. การศึกษาย้อนหลังการติดเชื้อไวรัส ฮิวแมนแพพพิวโลมาในประเทศไทย: การทบทวนอย่างเป็นระบบ. วารสารโรคมะเร็ง. 2565; 42(1):10-29.
Burd EM. Human Papillomavirus Laboratory Testing: the Changing Paradigm. Clin Microbiol Rev. 2016; 29(2):291-319.
Cubie HA, Cuschieri K. Understanding HPV tests and their appropriate applications. Cytopathology. 2013;24(5):289-308.
Dunbar S, Das S. Amplification chemistries in clinical virology. J Clin Virol. 2019; 115:18-31.
Yang H, Luo ZY, Lin F, et al. Comparison of Urine and Genital Samples for Detecting Human Papillomavirus (HPV) in Clinical Patients. Obstet Gynecol Int. 2023; 2023:1-8
World Health Organization. Human papillomavirus (HPV) self-sampling as part of cervical cancer screening and treatment, 2022 update; [internet]. 2023. [cite 2024 Nov 27] Available from: https://iris.who.int/bitstream/handle/10665/366868/WHO-SRH-23.1-eng.pdf.
กุลกานต์ พิศอ่อน. การเปรียบเทียบประสิทธิภาพการเก็บสิ่งส่งตรวจคัดกรองมะเร็งปากมดลูกด้วยวิธี HPV DNA ระหว่างเจ้าหน้าที่และเก็บด้วยตนเองในจังหวัดกำแพงเพชร. วารสารวิทยาศาสตร์สุขภาพ วิทยาลัยพยาบาลบรมราชชนนี สรรพสิทธิประสงค์. 2567; 8(1):e268431.
Chakravarti P, Maheshwari A, Tahlan S, et al. Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: a systematic review. Ecancermedicalscience. 2022; 16:1427.
Zhang J, Tian X, Chen Y, et al. Feasibility and Accuracy of Menstrual Blood Testing for High-risk Human Papillomavirus Detection With Capture Sequencing. JAMA Netw Open. 2021; 4(12):e2140644.
Medical Device network. Thailand FDA approves Qvin’s Q-Pad technology: 2023; [internet]. 2025 [cite 2025 Feb 08] Available from: https://www.medicaldevi
cenetwork.com/news/thailand-fda-qvin-q-pad/?utm_source=chatgpt.com&cf-view&cf-view&cf-closed
Bio Molecular Laboratories. ชุดเก็บตัวอย่างคิว-แพด เจาะลึกสุขภาพจากเลือดประจำเดือน QPad HPV DNA screening. N Health; [internet]. 2024 [cite 2025 Feb 08] Available from: https://www.nhealth-asia.com/th/blog/nhealth_50_qpad_hpv_dna_screening
Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis. 2006; 194(8):1044-57.
Markowitz LE, Schiller JT. Human Papillomavirus Vaccines. J Infect Dis. 2021; 224(12 Suppl 2): S367-s78.
Thailand PIDSo. Vaccination in Thai children and teenager: 2024 [internet]. 2024 [cite 2024 Nov 27] Available from: https://www.pidst.or.th/A1406.html.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Thammasat University Hospital Journal Online
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
